Angina Pectoris Drugs Market is expected to be USD 11.35 billion by 2023 | Crystal Market research
The Angina Pectoris Drugs Market research report provided by Crystal Market Research (CMR) is the most detailed study about Angina Pectoris Drugs that is estimated to grow at a tremendous rate over the forecast period 2018-2023. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Major Eminent Players: The major players in the Angina Pectoris Drugs Market are AstraZeneca, GlaxoSmithKline, Sanofi, Pfizer, Gilead Sciences, Eli Lilly and Company and Amgen. The Angina Pectoris Drugs Market is segmented as follows- By Therapeutic Class: Calcium Antagonists Anti-Platelets Beta Blockers Anticoagulants Others ACE inhibitors Nitrates Anti-anginal (Ranolazine) Industry Outlook and Trend Analysis: The Angina Pectoris Drugs Market was worth USD 8.24 billion in the year of 2014 and is expected to reach approximately USD 11.35 billion by 2023, while registering itself at a comp...